COVID-19 has already had an impact on our health and on our businesses. Politicians, health professionals, economists and business owners predict further challenges over the coming months. This of course raises disclosure issues for public companies.
We were interested in how Canadian public companies have dealt with COVID-19 issues in their public disclosure at this point in the crisis. We reviewed AIFs and MD&As published by TSX-listed companies for a recent 30 day period (February 19, 2020 and March 20, 2020).1 We compared these with the same documents published in 2019. We reviewed 1,264 documents in total…
Read the Full Article on Substack
The complete analysis, along with our full archive of publications, is now posted exclusively on our firm’s Substack.